#patientaccess — Public Fediverse posts

https://www.europesays.com/dk/127309/ NVO Rallies 11% in a Month: How Should Investors Play the Stock? #EliLilly #NovoNordisk #PatientAccess

https://www.europesays.com/dk/127105/ NVO Rallies 11% in a Month: How Should Investors Play the Stock? #EliLilly #NovoNordisk #PatientAccess

https://www.europesays.com/britain/79975/ Southeast Asia Oncology Drug Access Market Now Available; Profiles Roche, AstraZeneca, Merck, and Other Key Peers #Access #AccessMarket #AstraZeneca #MarketGrowth #MarketInsights #MarketSegmentation #OncologyDrug #OncologyDrugs #PatientAccess #PharmaceuticalCompanies #PrecisionMedicine #SoutheastAsia #StrategicInsights

https://www.europesays.com/ch/100628/ Southeast Asia Oncology Drug Access Market Now Available; Profiles Roche, AstraZeneca, Merck, and Other Key Peers #access #AccessMarket #MarketGrowth #MarketInsights #MarketSegmentation #OncologyDrug #OncologyDrugs #PatientAccess #PharmaceuticalCompanies #PrecisionMedicine #Roche #SoutheastAsia #StrategicInsights

European patient access to new drugs worsens, pharma lobby says

By Maggie Fick and Bhanvi Satija LONDON, June 22 (Reuters) – Patient access to new medicines is worsening…
#Europe #EU #EFPIA #European #Europeancountries #Europeangovernments #hospitalcosts #patientaccess #PresidentDonaldTrump #TheEuropeanFederationofPharmaceuticalIndustriesandAssociations #workforceproductivity
https://www.europesays.com/europe/76602/

https://www.europesays.com/ch/86564/ Novartis in Albania | Novartis Albania #GeneTherapy #HealthcareInnovation #InnovativeMedicines #MedicalEducationellTherapy #Novartis #NovartisAlbania #PatientAccess #ResearchAndDevelopment

https://www.europesays.com/ch/84403/ Novartis launches Pluvicto®, the Country’s First Regulatory Authority Approved Radioligand Therapy for Advanced Prostate Cancer #AdvancedProstateCancer #ClinicalInnovation #HealthcareIndia #MetastaticProstateCancer #Novartis #NovartisIndia #NuclearMedicine #OncologyTreatments #PatientAccess #Pluvicto #PluvictoIndia #PrecisionOncology #ProstateCancer #PSMA #RadioligandTherapy

https://www.europesays.com/dk/106661/ Novo Nordisk’s Wegovy pill approved in the UK #NovoNordisk #Obesity #PatientAccess #semaglutide #Wegovy #WegovyPill #WeightLossDrugs

Keona Health reveals manual nursing triage costs healthcare organizations millions in hidden expenses. AI-assisted triage achieves 93% accuracy vs. 59-82% for manual processes, reducing ED referrals and onboarding time. #Healthcare #PatientAccess

Keona Health reveals manual nursing triage costs healthcare organizations millions in hidden expenses. AI-assisted triage achieves 93% accuracy vs. 59-82% for manual processes, reducing ED referrals and onboarding time. #Healthcare #PatientAccess

Keona Health reveals manual nursing triage costs healthcare organizations millions in hidden expenses. AI-assisted triage achieves 93% accuracy vs. 59-82% for manual processes, reducing ED referrals and onboarding time. #Healthcare #PatientAccess

Keona Health reveals manual nursing triage costs healthcare organizations millions in hidden expenses. AI-assisted triage achieves 93% accuracy vs. 59-82% for manual processes, reducing ED referrals and onboarding time. #Healthcare #PatientAccess

https://www.europesays.com/uk/954020/ Tonix Pharmaceuticals Reports First Quarter 2026 Financial Results and Operational Highlights #company #Health #Healthcare #PatientAccess #Prescriptions #TheCompany #TonixPharmaceuticals #UK #UnitedKingdom

Tonix Pharmaceuticals Reports First Quarter 2026 Financial Results and Operational Highlights

Tonix Pharmaceuticals Holding Corp. In the first full quarter since launch, 2,145 healthcare providers prescribed TONMYA®, 3,588 patients…
#NewsBeep #News #Healthcare #AU #Australia #Company #Health #patientaccess #Prescriptions #TheCompany #TonixPharmaceuticals
https://www.newsbeep.com/au/665082/

Tonix Pharmaceuticals Reports First Quarter 2026 Financial Results and Operational Highlights

Tonix Pharmaceuticals Holding Corp. In the first full quarter since launch, 2,145 healthcare providers prescribed TONMYA®, 3,588 patients…
#NewsBeep #News #Healthcare #AU #Australia #Company #Health #patientaccess #Prescriptions #TheCompany #TonixPharmaceuticals
https://www.newsbeep.com/au/665082/

Tonix Pharmaceuticals Reports First Quarter 2026 Financial Results and Operational Highlights

Tonix Pharmaceuticals Holding Corp. In the first full quarter since launch, 2,145 healthcare providers prescribed TONMYA®, 3,588 patients…
#NewsBeep #News #Healthcare #CA #Canada #company #Health #patientaccess #Prescriptions #TheCompany #TonixPharmaceuticals
https://www.newsbeep.com/ca/663476/

Tonix Pharmaceuticals Reports First Quarter 2026 Financial Results and Operational Highlights

Tonix Pharmaceuticals Holding Corp. In the first full quarter since launch, 2,145 healthcare providers prescribed TONMYA®, 3,588 patients…
#NewsBeep #News #Healthcare #company #Health #healthcare #patientaccess #Prescriptions #TheCompany #TonixPharmaceuticals #UK #UnitedKingdom
https://www.newsbeep.com/uk/579070/

https://www.europesays.com/ie/480097/ Tonix Pharmaceuticals Reports First Quarter 2026 Financial Results and Operational Highlights #Company #Éire #Health #HealthCare #Healthcare #IE #Ireland #PatientAccess #Prescriptions #TheCompany #TonixPharmaceuticals

https://www.europesays.com/dk/78338/ Amazon Pharmacy Access To Ozempic Pills Tests Novo Nordisk Pricing Power #AmazonPharmacy #DistributionLayer #NovoNordisk #PatientAccess #WeightWatchers

https://www.europesays.com/africa/214889/ What the U.S. Pharmaceutical Industry Could Learn from How Africa Solves Patient Access #Africa #AmericanHealthcare #Infrastructure #MedicationAdherence #NovoNordisk #PatientAccess #patients #PharmaceuticalValueChain #SubSaharanAfrica #TheUnitedStates #VictorUnanah #WestAfrica

TLX101-Px (Pixlumi®) MAA Accepted in Europe

MELBOURNE, Australia and INDIANAPOLIS, May 1, 2026 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces…
#Europe #EU #clinicalpracticeguidelines #patientaccess #PETimaging #regulatoryapproval
https://www.europesays.com/europe/27869/

European health chief says EU is at ‘a critical point’ in ensuring new drug access

By Maggie Fick BARCELONA, April 22 (Reuters) – Europe is at a critical juncture for ensuring future access…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Healthcare #criticaljuncture #EmerCooke #Europe #EuropeanMedicinesAgency #Health #patientaccess #Pharmaceuticals #PresidentDonaldTrump #pricingpolicy
https://www.newsbeep.com/us/601178/

European health chief says EU is at ‘a critical point’ in ensuring new drug access

By Maggie Fick BARCELONA, April 22 (Reuters) – Europe is at a critical juncture for ensuring future access…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Healthcare #criticaljuncture #EmerCooke #Europe #EuropeanMedicinesAgency #Health #patientaccess #Pharmaceuticals #PresidentDonaldTrump #pricingpolicy
https://www.newsbeep.com/us/601178/

European health chief says EU is at ‘a critical point’ in ensuring new drug access

By Maggie Fick BARCELONA, April 22 (Reuters) – Europe is at a critical juncture for ensuring future access…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Healthcare #criticaljuncture #EmerCooke #Europe #EuropeanMedicinesAgency #Health #patientaccess #Pharmaceuticals #PresidentDonaldTrump #pricingpolicy
https://www.newsbeep.com/us/601178/

Definition of opportunity cost for a medical practice:

The revenue, growth, or patient care you lose by choosing one operational path over a better alternative.

https://youtu.be/YplSId4Gmns

#HealthcareOperations #MedicalPracticeManagement #OpportunityCost #PracticeGrowth #PatientAccess #HealthcareEfficiency #RevenueCycle #PracticeManagement #HealthcareLeadership #MedicalPracticeGrowth #PatientExperience #OperationalEfficiency #HealthcareInnovation #PracticeOptimization #MissedOpportunities

GPs SHIFTING GATEKEEPING ROLES TO AI, PATIENTS REPORT DIFFICULTY ACCESSING CARE

Patients find it hard to book GP appointments as AI chatbots replace receptionists. Some are switching doctors. Learn why.

#GPAppointments, #AIinHealthcare, #PatientAccess, #DigitalHealth, #NHS

https://newsletter.tf/gp-ai-receptionists-make-appointments-hard-to-get/

Patients are finding it harder to get GP appointments, with some describing AI systems making them 'unobtainable'. This is a change from previous systems.

#GPAppointments, #AIinHealthcare, #PatientAccess, #DigitalHealth, #NHS
https://newsletter.tf/gp-ai-receptionists-make-appointments-hard-to-get/

Apomeds Enters the UK Market With Its Digital Healthcare Platform https://www.byteseu.com/1930691/ #AlternativeTreatment #DigitalHealthcare #DigitalPlatform #England #GreatBritain #NHSEngland #OnlineAccess #OnlineMarketplace #PatientAccess #PatientDemand #patients #UnitedKingdom #WEYBRIDGE

https://www.europesays.com/uk/885178/ Apomeds Enters the UK Market With Its Digital Healthcare Platform #AlternativeTreatment #Britain #DigitalHealthcare #DigitalPlatform #England #GreatBritain #NHSEngland #NorthernIreland #OnlineAccess #OnlineMarketplace #PatientAccess #PatientDemand #patients #Scotland #UK #UnitedKingdom #Wales #Weybridge

https://www.europesays.com/britain/11306/ Apomeds Enters the UK Market With Its Digital Healthcare Platform #AlternativeTreatment #DigitalHealthcare #DigitalPlatform #England #NHSEngland #OnlineAccess #OnlineMarketplace #PatientAccess #PatientDemand #Patients #UK #UnitedKingdom #WEYBRIDGE

https://www.europesays.com/dk/55073/ LifeMD Offers Novo Nordisk’s Industry-First Wegovy® Telehealth Subscription Program #ForwardLookingStatements #LifeMD #NovoNordisk #PatientAccess #PatientCare #SubscriptionModel #SubscriptionProgram #VirtualPrimaryCareServices #WeightManagement

https://www.europesays.com/dk/53527/ LifeMD Offers Novo Nordisk’s Industry-First Wegovy® Telehealth Subscription Program #ForwardLookingStatements #LifeMD #NovoNordisk #PatientAccess #PatientCare #SubscriptionModel #SubscriptionProgram #VirtualPrimaryCareServices #WeightManagement

https://www.europesays.com/dk/43676/ Novo Nordisk patent expiry opens door to cheaper weight-loss drugs in India #Diabetes #DrugPricing #India #NovoNordisk #Obesity #patents #PatientAccess #semaglutide #WeightLossDrugs

https://www.europesays.com/dk/36356/ Novo Nordisk expands U.S. patient access to FDA-approved semaglutide medicines through Hims & Hers #GLP1 #Hims&Hers #NovoNordisk #Obesity #ozempic #PatentInfringement #PatientAccess #semaglutide #Wegovy #WeightLossDrugs

340B Drug Pricing Program Under Scrutiny: Examining Program Goals and Real-World Effects

The 340B program helps hospitals get cheaper drugs for poor patients. Learn how it works and why it's being discussed.

#340BProgram, #DrugPricing, #HealthcareCosts, #PatientAccess, #HospitalSavings

https://newsletter.tf/340b-drug-program-how-hospitals-get-cheaper-drugs-for-poor-patients/

340B Drug Pricing Program Under Scrutiny: Examining Program Goals and Real-World Effects

The 340B program helps hospitals get cheaper drugs for poor patients. Learn how it works and why it's being discussed.

#340BProgram, #DrugPricing, #HealthcareCosts, #PatientAccess, #HospitalSavings

https://newsletter.tf/340b-drug-program-how-hospitals-get-cheaper-drugs-for-poor-patients/

The 340B program helps hospitals get drugs for low-income patients at lower prices. This program is now being looked at closely by the government.

#340BProgram, #DrugPricing, #HealthcareCosts, #PatientAccess, #HospitalSavings

https://newsletter.tf/340b-drug-program-how-hospitals-get-cheaper-drugs-for-poor-patients/

The 340B program helps hospitals get drugs for low-income patients at lower prices. This program is now being looked at closely by the government.

#340BProgram, #DrugPricing, #HealthcareCosts, #PatientAccess, #HospitalSavings

https://newsletter.tf/340b-drug-program-how-hospitals-get-cheaper-drugs-for-poor-patients/

https://www.europesays.com/ie/354821/ Novo Nordisk announces significant reduction in US list price for Wegovy®, Ozempic®, and Rybelsus® (semaglutide medicines), building on continued efforts to expand access #Éire #GallbladderProblems #Health #HealthCare #Healthcare #HealthcareProvider #IE #Ireland #KidneyProblems #ListPrice #NovoNordisk #ozempic #PatientAccess #PrescriptionMedicines #SideEffects #ThyroidCancer #Type2Diabetes

Europe votes to expand abortion access in historic vote – POLITICO https://www.byteseu.com/1635605/ ##WomensHealth #AbirAlSahlani #abortion #Equality #Europe #GenderEquality #HadjaLahbib #Malta #PatientAccess #Poland #Rights #TheNetherlands #UnitedKingdom

Improve patient access and deliver convenient, reliable, and equitable virtual health services. 🌍

RAVCARE bridges the gap between technology and healthcare, fostering a healthier, more connected world for your patients. Give your patients the convenience they deserve.

#PatientAccess #TelehealthBenefits #ConvenientCare #EquitableHealthcare #VirtualMedicine

WHO demands countries step up mental health spending – POLITICO

Governments in WHO’s Europe region spent $51.76 per capita in 2024 on mental health, far more than any…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Mentalhealth #Health #healthsystems #MentalHealth #patientaccess
https://www.newsbeep.com/us/127309/

The end of GLP-1 drug shortages (Ozempic, Zepbound) is a mixed blessing. Supply is up, but affordable compounded versions are vanishing, leaving many patients anxious about affording crucial meds & keeping their health gains. #WeightLossDrugs #Pharma #PatientAccess

#SCOTUS’ decision not to wade into the #abortion-related matter is a setback for abortion opponents. But it follows the #Trump admin’s announcement that it will scale back #Biden-era efforts to prosecute demonstrators who interfere w/ #PatientAccess to #ReproductiveHealth clinics. The #DOJ instructed its #CivilRights division last month to drop 3 pending actions brought under the Freedom of Access to Clinic Entrances (#Face) Act, involving blockades in #Ohio, #Tennessee & #Pennsylvania.

#law

#SCOTUS’ decision not to wade into the #abortion-related matter is a setback for abortion opponents. But it follows the #Trump admin’s announcement that it will scale back #Biden-era efforts to prosecute demonstrators who interfere w/ #PatientAccess to #ReproductiveHealth clinics. The #DOJ instructed its #CivilRights division last month to drop 3 pending actions brought under the Freedom of Access to Clinic Entrances (#Face) Act, involving blockades in #Ohio, #Tennessee & #Pennsylvania.

#law

#SCOTUS’ decision not to wade into the #abortion-related matter is a setback for abortion opponents. But it follows the #Trump admin’s announcement that it will scale back #Biden-era efforts to prosecute demonstrators who interfere w/ #PatientAccess to #ReproductiveHealth clinics. The #DOJ instructed its #CivilRights division last month to drop 3 pending actions brought under the Freedom of Access to Clinic Entrances (#Face) Act, involving blockades in #Ohio, #Tennessee & #Pennsylvania.

#law

#SCOTUS’ decision not to wade into the #abortion-related matter is a setback for abortion opponents. But it follows the #Trump admin’s announcement that it will scale back #Biden-era efforts to prosecute demonstrators who interfere w/ #PatientAccess to #ReproductiveHealth clinics. The #DOJ instructed its #CivilRights division last month to drop 3 pending actions brought under the Freedom of Access to Clinic Entrances (#Face) Act, involving blockades in #Ohio, #Tennessee & #Pennsylvania.

#law

Ugh, #PatientAccess is down.

Ugh, #PatientAccess is down.

Ugh, #PatientAccess is down.